when does the patent for semaglutide expire expiration us As patents on semaglutide, a popular diabetes and anti-obesity drug Looming GLP-1 drug patent expirations
Description
QID, four times daily
As of August 2025, stomach paralysis and related digestive injuries account for the vast majority of the 1,800+ pending cases, though NAION claims are rapidly increasing
Journal of Cosmetic Dermatology (2024 Jan;23(1))
Studies show that GLP-1 medications can impact gastric motility, which can contribute to symptoms like bloating and side effects like sulfur burps, especially in people who are sensitive to changes in their digestion
)
Clinical experience shows that most patients detect changes in their relationship with food by day 5-7
